生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | The NS3 protein is a chymotrypsin-like serine protease that is activated by association with NS4A. NS3/4A (nonstructural protein 3/4A) liberates the functional form of the viral polymerase and other viral proteins required for HCV replication. Danoprevir is a peptidomimetic inhibitor of the NS3/4A protease of HCV with an IC50 rang of 0.2 - 3.5 nM. In peptide cleavage assays, danoprevir reduced genotype 1b NS3/4A protease activity in a concentration-dependent fashion. Dose-dependent reductions of a patient-derived HCV genotype 1b replicon harbored in hepatocyte-derived Huh7 cells were observed following 2-day incubation with danoprevir. In any case, treatment with 45 nM danoprevir (3 times its EC90) reduced HCV replicon RNA levels below the RT-PCR detection limit in a sustained fashion and completely cleared replicon RNA. In monkey liver tissue, the maximum concentration in the liver (Cmax) and the 12-h-postdose concentration in the liver (C12 h) were sufficient to reduce HCV replicon RNA by 3.1 log10 and 2.0 log10 units, respectively[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.37mL 0.27mL 0.14mL |
6.83mL 1.37mL 0.68mL |
13.66mL 2.73mL 1.37mL |
参考文献 |
---|